Cargando…
Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
BACKGROUND: Idiopathic Parkinson’s disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ clinically since the neuropathological substrate of LRRK2-PD is heterogeneous. The range and severity of extra-nigral nonmotor features associated with LRRK2 mutations is also not well-def...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201457/ https://www.ncbi.nlm.nih.gov/pubmed/25330404 http://dx.doi.org/10.1371/journal.pone.0108982 |
_version_ | 1782340175196585984 |
---|---|
author | Gaig, Carles Vilas, Dolores Infante, Jon Sierra, María García-Gorostiaga, Inés Buongiorno, Mariateresa Ezquerra, Mario Martí, Maria José Valldeoriola, Francesc Aguilar, Miquel Calopa, Matilde Hernandez-Vara, Jorge Tolosa, Eduardo |
author_facet | Gaig, Carles Vilas, Dolores Infante, Jon Sierra, María García-Gorostiaga, Inés Buongiorno, Mariateresa Ezquerra, Mario Martí, Maria José Valldeoriola, Francesc Aguilar, Miquel Calopa, Matilde Hernandez-Vara, Jorge Tolosa, Eduardo |
author_sort | Gaig, Carles |
collection | PubMed |
description | BACKGROUND: Idiopathic Parkinson’s disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ clinically since the neuropathological substrate of LRRK2-PD is heterogeneous. The range and severity of extra-nigral nonmotor features associated with LRRK2 mutations is also not well-defined. OBJECTIVE: To evaluate the prevalence and time of onset of nonmotor symptoms (NMS) in LRRK2-PD patients. METHODS: The presence of hyposmia and of neuropsychiatric, dysautonomic and sleep disturbances was assessed in 33 LRRK2-G2019S-PD patients by standardized questionnaires and validated scales. Thirty-three IPD patients, matched for age, gender, duration of parkinsonism and disease severity and 33 healthy subjects were also evaluated. RESULTS: University of Pennsylvania Smell Identification Test (UPSIT) scores in LRRK2-G2019S-PD were higher than those in IPD (23.5±6.8 vs 18.4±6.0; p = 0.002), and hyposmia was less frequent in G2019S carriers than in IPD (39.4% vs 75.8%; p = 0.01). UPSIT scores were significantly higher in females than in males in LRRK2-PD patients (26.9±4.7 vs 19.4±6.8; p<0.01). The frequency of sleep and neuropsychiatric disturbances and of dysautonomic symptoms in LRRK2-G2019S-PD was not significantly different from that in IPD. Hyposmia, depression, constipation and excessive daytime sleepiness, were reported to occur before the onset of classical motor symptoms in more than 40% of LRRK2-PD patients in whom these symptoms were present at the time of examination. CONCLUSION: Neuropsychiatric, dysautonomic and sleep disturbances occur as frequently in patients with LRRK2-G2019S-PD as in IPD but smell loss was less frequent in LRRK2-PD. Like in IPD, disturbances such as hyposmia, depression, constipation and excessive daytime sleepiness may antedate the onset of classical motor symptoms in LRRK2-G2019S-PD. |
format | Online Article Text |
id | pubmed-4201457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42014572014-10-21 Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease Gaig, Carles Vilas, Dolores Infante, Jon Sierra, María García-Gorostiaga, Inés Buongiorno, Mariateresa Ezquerra, Mario Martí, Maria José Valldeoriola, Francesc Aguilar, Miquel Calopa, Matilde Hernandez-Vara, Jorge Tolosa, Eduardo PLoS One Research Article BACKGROUND: Idiopathic Parkinson’s disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ clinically since the neuropathological substrate of LRRK2-PD is heterogeneous. The range and severity of extra-nigral nonmotor features associated with LRRK2 mutations is also not well-defined. OBJECTIVE: To evaluate the prevalence and time of onset of nonmotor symptoms (NMS) in LRRK2-PD patients. METHODS: The presence of hyposmia and of neuropsychiatric, dysautonomic and sleep disturbances was assessed in 33 LRRK2-G2019S-PD patients by standardized questionnaires and validated scales. Thirty-three IPD patients, matched for age, gender, duration of parkinsonism and disease severity and 33 healthy subjects were also evaluated. RESULTS: University of Pennsylvania Smell Identification Test (UPSIT) scores in LRRK2-G2019S-PD were higher than those in IPD (23.5±6.8 vs 18.4±6.0; p = 0.002), and hyposmia was less frequent in G2019S carriers than in IPD (39.4% vs 75.8%; p = 0.01). UPSIT scores were significantly higher in females than in males in LRRK2-PD patients (26.9±4.7 vs 19.4±6.8; p<0.01). The frequency of sleep and neuropsychiatric disturbances and of dysautonomic symptoms in LRRK2-G2019S-PD was not significantly different from that in IPD. Hyposmia, depression, constipation and excessive daytime sleepiness, were reported to occur before the onset of classical motor symptoms in more than 40% of LRRK2-PD patients in whom these symptoms were present at the time of examination. CONCLUSION: Neuropsychiatric, dysautonomic and sleep disturbances occur as frequently in patients with LRRK2-G2019S-PD as in IPD but smell loss was less frequent in LRRK2-PD. Like in IPD, disturbances such as hyposmia, depression, constipation and excessive daytime sleepiness may antedate the onset of classical motor symptoms in LRRK2-G2019S-PD. Public Library of Science 2014-10-17 /pmc/articles/PMC4201457/ /pubmed/25330404 http://dx.doi.org/10.1371/journal.pone.0108982 Text en © 2014 Gaig et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gaig, Carles Vilas, Dolores Infante, Jon Sierra, María García-Gorostiaga, Inés Buongiorno, Mariateresa Ezquerra, Mario Martí, Maria José Valldeoriola, Francesc Aguilar, Miquel Calopa, Matilde Hernandez-Vara, Jorge Tolosa, Eduardo Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease |
title | Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease |
title_full | Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease |
title_fullStr | Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease |
title_full_unstemmed | Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease |
title_short | Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease |
title_sort | nonmotor symptoms in lrrk2 g2019s associated parkinson’s disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201457/ https://www.ncbi.nlm.nih.gov/pubmed/25330404 http://dx.doi.org/10.1371/journal.pone.0108982 |
work_keys_str_mv | AT gaigcarles nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT vilasdolores nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT infantejon nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT sierramaria nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT garciagorostiagaines nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT buongiornomariateresa nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT ezquerramario nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT martimariajose nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT valldeoriolafrancesc nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT aguilarmiquel nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT calopamatilde nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT hernandezvarajorge nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease AT tolosaeduardo nonmotorsymptomsinlrrk2g2019sassociatedparkinsonsdisease |